Alerts

Monitoring communication

New conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.

Changes to radio frequency (RF) spectrums in Australia could affect a small number of biomedical telemetry devices used in hospitals.

Hazard alert due to potential for breakage.

The TGA warns that Plexus Slim Accelerator Capsules and the 3-Day Trial Pack are unsafe and illegal in Australia because they contain a banned substance that can cause serious health problems.

Hydroxyethyl starch (Voluven and Volulyte) and increased risk of mortality

Yong Gang tablets contain undeclared prescription substances and pose serious health risks. Stop using them and return any remaining tablets to your pharmacy. Consult your doctor if you have concerns.

The TGA has issued updated safety advice for health professionals regarding dabigatran (Pradaxa), highlighting the increased risk of bleeding and the importance of careful patient selection and monitoring, especially in older adults and those with kidney impairment.

TGA has issued updated safety advice for consumers taking Pradaxa (dabigatran), highlighting risks such as bleeding and the importance of proper storage and patient monitoring.